We demonstrated that overexpression of BYSL elevated the RIOK2 and mTOR protein levels and that they existed in the same complex in glioma cells, but we did not show whether their interactions were enhanced in glioma cells/tissues that highly expressed BYSL. This evidence concerns the gene RIOK2 and central nervous system cancer.